{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:48:44Z","timestamp":1778744924614,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","award":["T7342"],"award-info":[{"award-number":["T7342"]}],"id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","award":["G-13-0001610"],"award-info":[{"award-number":["G-13-0001610"]}],"id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007476","name":"Canadian Diabetes Association","doi-asserted-by":"publisher","award":["OG-3-09-2830-AG"],"award-info":[{"award-number":["OG-3-09-2830-AG"]}],"id":[{"id":"10.13039\/100007476","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Heart and Stroke Foundation of Manitoba","award":["000402"],"award-info":[{"award-number":["000402"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.metabol.2016.12.002","type":"journal-article","created":{"date-parts":[[2016,12,10]],"date-time":"2016-12-10T03:45:44Z","timestamp":1481341544000},"page":"108-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["High-dose metformin (420 mg\/kg daily p.o.) increases insulin sensitivity but does not affect neointimal thickness in the rat carotid balloon injury model of restenosis"],"prefix":"10.1016","volume":"68","author":[{"given":"June","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Troy J.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasad","family":"Dalvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy Shu Nga","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Swain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danna M.","family":"Breen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loretta","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vernon W.","family":"Dolinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adria","family":"Giacca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2016.12.002_bb0005","series-title":"Global report on diabetes","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.metabol.2016.12.002_bb0010","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1161\/01.CIR.0000013957.30622.05","article-title":"Prevention conference VI: diabetes and cardiovascular disease: writing group VI: revascularization in diabetic patients","volume":"105","author":"Smith","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2016.12.002_bb0015","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1161\/01.CIR.0000129767.45513.71","article-title":"Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy","volume":"109","author":"Moussa","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2016.12.002_bb0020","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000281581","article-title":"Insulin inhibits and oral sucrose increases neointimal growth after arterial injury in rats","volume":"47","author":"Breen","year":"2010","journal-title":"J Vasc Res"},{"key":"10.1016\/j.metabol.2016.12.002_bb0025","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1161\/01.ATV.0000069210.46539.0D","article-title":"Troglitazone stimulates repair of the endothelium and inhibits neointimal formation in denuded rat aorta","volume":"23","author":"Hannan","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2016.12.002_bb0030","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1159\/000088099","article-title":"Anti-atherogenic effect of insulin in vivo","volume":"42","author":"Kim","year":"2005","journal-title":"J Vasc Res"},{"key":"10.1016\/j.metabol.2016.12.002_bb0035","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cmet.2016.05.011","article-title":"Metformin as a tool to target aging","volume":"23","author":"Barzilai","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2016.12.002_bb0040","doi-asserted-by":"crossref","first-page":"40706","DOI":"10.18632\/oncotarget.8194","article-title":"Repurposing metformin for cancer treatment: current clinical studies","volume":"7","author":"Chae","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.metabol.2016.12.002_bb0045","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2016.12.002_bb0050","first-page":"225","article-title":"Metformin attenuates progression of carotid arterial wall thickness in patients with type 2 diabetes","volume":"64","author":"Matsumoto","year":"2004","journal-title":"Diabetes ResClinPract"},{"key":"10.1016\/j.metabol.2016.12.002_bb0055","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1440-1681.2008.04920.x","article-title":"Metformin, arterial function, intima-media thickness and nitroxidation in metabolic syndrome: the mefisto study","volume":"35","author":"Meaney","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.metabol.2016.12.002_bb0060","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S2213-8587(13)70152-9","article-title":"Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial","volume":"2","author":"Preiss","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2016.12.002_bb0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0021-9150(83)90066-7","article-title":"Metformin action on lipid metabolism in lesions of experimental aortic atherosclerosis of rabbits","volume":"47","author":"Marquie","year":"1983","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2016.12.002_bb0070","doi-asserted-by":"crossref","first-page":"e001202","DOI":"10.1161\/JAHA.114.001202","article-title":"Metformin beyond diabetes: pleiotropic benefits of metformin in attenuation of atherosclerosis","volume":"3","author":"Forouzandeh","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.metabol.2016.12.002_bb0075","article-title":"Metformin suppresses diabetes-accelerated atherosclerosis via the inhibition of Drp1-mediated mitochondrial fission","author":"Wang","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2016.12.002_bb0080","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1210\/en.2012-1937","article-title":"GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE\u2212\/\u2212 mice","volume":"154","author":"Panjwani","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2016.12.002_bb0085","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1126\/science.1120781","article-title":"The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin","volume":"310","author":"Shaw","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.metabol.2016.12.002_bb0090","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1172\/JCI40671","article-title":"Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1\/AMPK pathway via a decrease in hepatic energy state","volume":"120","author":"Foretz","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2016.12.002_bb0095","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bbrc.2012.04.052","article-title":"Metformin-induced AMP-activated protein kinase activation regulates phenylephrine-mediated contraction of rat aorta","volume":"421","author":"Sung","year":"2012","journal-title":"Biochem Biophys Res Commun."},{"key":"10.1016\/j.metabol.2016.12.002_bb0100","doi-asserted-by":"crossref","first-page":"H369","DOI":"10.1152\/ajpheart.00446.2012","article-title":"AMP-activated protein kinase inhibits vascular smooth muscle cell proliferation and migration and vascular remodeling following injury","volume":"304","author":"Stone","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2016.12.002_bb0105","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1161\/CIRCRESAHA.111.250423","article-title":"AMPKalpha2 deletion exacerbates neointima formation by upregulating Skp2 in vascular smooth muscle cells","volume":"109","author":"Song","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2016.12.002_bb0110","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/01.CIR.0000136025.96811.76","article-title":"AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation","volume":"110","author":"Nagata","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2016.12.002_bb0115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1475-2840-8-41","article-title":"The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus","volume":"8","author":"Lexis","year":"2009","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2016.12.002_bb0120","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.amjcard.2004.02.028","article-title":"Relation of metformin treatment to clinical events in diabetic patients undergoing percutaneous intervention","volume":"93","author":"Kao","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.metabol.2016.12.002_bb0125","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/0003319707303587","article-title":"Angiographic and clinical outcomes of rosiglitazone in patients with type 2 diabetes mellitus after percutaneous coronary interventions: a single center experience","volume":"58","author":"Fang","year":"2007","journal-title":"Angiology"},{"key":"10.1016\/j.metabol.2016.12.002_bb0130","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1475-2840-12-58","article-title":"The protective effect and underlying mechanism of metformin on neointima formation in fructose-induced insulin resistant rats","volume":"12","author":"Lu","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2016.12.002_bb0135","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S0022-3565(25)24016-2","article-title":"Antihypertensive effects of metformin in fructose-fed hyperinsulinemic, hypertensive rats","volume":"271","author":"Verma","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.metabol.2016.12.002_bb0140","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.atherosclerosis.2012.03.021","article-title":"Resveratrol inhibits neointimal formation after arterial injury through an endothelial nitric oxide synthase-dependent mechanism","volume":"222","author":"Breen","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2016.12.002_bb0145","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-2613.2000.00143.x","article-title":"The mechanisms of coronary restenosis: insights from experimental models","volume":"81","author":"Ferns","year":"2000","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.metabol.2016.12.002_bb0150","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2353\/ajpath.2008.071046","article-title":"Integrin-linked kinase in the vascular smooth muscle cell response to injury","volume":"173","author":"Ho","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.metabol.2016.12.002_bb0155","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.bbrc.2012.07.165","article-title":"Metformin inhibits inflammatory response via AMPK\u2013PTEN pathway in vascular smooth muscle cells","volume":"425","author":"Kim","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2016.12.002_bb0160","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nrcardio.2011.132","article-title":"Restenosis after PCI. Part 1: pathophysiology and risk factors","volume":"9","author":"Jukema","year":"2012","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.metabol.2016.12.002_bb0165","first-page":"E95","article-title":"Hypertension and sympathetic hyperactivity induced in rats by high-fat or glucose diets","volume":"260","author":"Kaufman","year":"1991","journal-title":"Am J Physiol"},{"key":"10.1016\/j.metabol.2016.12.002_bb0170","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nature11808","article-title":"Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP","volume":"494","author":"Miller","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2016.12.002_bb0175","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0735-1097(00)00679-3","article-title":"8-chloro-cAMP inhibits smooth muscle cell proliferation in vitro and neointima formation induced by balloon injury in vivo","volume":"36","author":"Indolfi","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2016.12.002_bb0180","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/sj.emboj.7600667","article-title":"Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction","volume":"24","author":"Sakamoto","year":"2005","journal-title":"EMBO J"},{"key":"10.1016\/j.metabol.2016.12.002_bb0185","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11010-007-9575-6","article-title":"AICAR induces phosphorylation of AMPK in an ATM-dependent, LKB1-independent manner","volume":"306","author":"Sun","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.metabol.2016.12.002_bb0190","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.cmet.2010.04.001","article-title":"Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation","volume":"11","author":"Hawley","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2016.12.002_bb0195","doi-asserted-by":"crossref","first-page":"43940","DOI":"10.1074\/jbc.M404421200","article-title":"Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species","volume":"279","author":"Zou","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2016.12.002_bb0200","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.freeradbiomed.2009.02.019","article-title":"Hypoxic activation of AMPK is dependent on mitochondrial ROS but independent of an increase in AMP\/ATP ratio","volume":"46","author":"Emerling","year":"2009","journal-title":"J Free Radic Biol Med"},{"key":"10.1016\/j.metabol.2016.12.002_bb0205","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.atherosclerosis.2011.11.002","article-title":"Hydrogen-rich saline prevents neointima formation after carotid balloon injury by suppressing ROS and the TNF-a\/NF-kB pathway","volume":"220","author":"Qin","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2016.12.002_bb0210","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cell.2012.01.017","article-title":"Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases","volume":"148","author":"Park","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2016.12.002_bb0215","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jacc.2012.12.018","article-title":"Metformin impairs vascular endothelial recovery after stent placement in the setting of locally eluted mammalian target of rapamycin inhibitors via S6 kinase-dependent inhibition of cell proliferation","volume":"61","author":"Habib","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2016.12.002_bb0220","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2337\/diab.40.11.1397","article-title":"Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats","volume":"40","author":"Kraegen","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2016.12.002_bb0225","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.2337\/db11-1399","article-title":"Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS\u2013Akt complex","volume":"61","author":"Zhang","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2016.12.002_bb0230","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.metabol.2008.10.003","article-title":"Nonesterified fatty acid exposure activates protective and mitogenic pathways in vascular smooth muscle cells by alternate signaling pathways","volume":"58","author":"Schauer","year":"2009","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2016.12.002_bb0235","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/01.RES.78.1.38","article-title":"Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury","volume":"78","author":"Bendeck","year":"1996","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2016.12.002_bb0240","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/pds.1598","article-title":"Coronary heart disease outcomes in patients receiving antidiabetic agents in the PharMetrics database 2000\u20132007","volume":"17","author":"Walker","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.metabol.2016.12.002_bb0245","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000355574","article-title":"Protective effect of metformin on myocardial injury in metabolic syndrome patients following percutaneous coronary intervention","volume":"127","author":"Li","year":"2014","journal-title":"Cardiology"},{"key":"10.1016\/j.metabol.2016.12.002_bb0250","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2174\/187152512800388948","article-title":"PPAR-gamma agonist in treatment of diabetes: cardiovascular safety considerations","volume":"10","author":"Abbas","year":"2012","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"10.1016\/j.metabol.2016.12.002_bb0255","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cmet.2012.04.003","article-title":"SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function","volume":"15","author":"Price","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2016.12.002_bb0260","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cmet.2011.05.009","article-title":"Adiponectin is required for PPARgamma-mediated improvement of endothelial function in diabetic mice","volume":"14","author":"Wong","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2016.12.002_bb0265","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.imbio.2015.06.016","article-title":"TLR4 antagonist attenuates atherogenesis in LDL receptor-deficient mice with diet-induced type 2 diabetes","volume":"220","author":"Lu","year":"2015","journal-title":"Immunobiology"},{"key":"10.1016\/j.metabol.2016.12.002_bb0270","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1124\/jpet.116.232934","article-title":"Inhibition of the inflammasome NLRP3 by arglabin attenuates inflammation, protects pancreatic beta-cells from apoptosis, and prevents type 2 diabetes mellitus development in ApoE2Ki mice on a chronic high-fat diet","volume":"357","author":"Abderrazak","year":"2016","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049516301767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049516301767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:13:07Z","timestamp":1758427987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049516301767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":54,"alternative-id":["S0026049516301767"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2016.12.002","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-dose metformin (420mg\/kg daily p.o.) increases insulin sensitivity but does not affect neointimal thickness in the rat carotid balloon injury model of restenosis","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2016.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}